Searchable abstracts of presentations at key conferences in endocrinology

ea0034oc6.5 | Clinical | SFEBES2014

Effectiveness of metyrapone in 195 patients with Cushing's syndrome

Daniel Eleni , Aylwin Simon , Mustafa Omar , Ball Steve , Munir Atif , Boelaert Kristien , Chortis Vasileios , Cuthbertson Daniel J , Daousi Christina , Rajeev Surya , Davis Julian , Cheer Kelly , Drake William , Gunganah Kirun , Grossman Ashley , Gurnell Mark , Powlson Andrew , Karavitaki Niki , Huquet Isabel , Kearney Tara , Mohit Kumar , Meeran Karim , Hill Neil , Rees Aled , Trainer Peter J , Lansdown Andrew J , Minder Anna-Elisabeth H , Newell-Price John

Background: Metyrapone is widely used in the UK for the control of cortisol excess in Cushing’s syndrome, but its use is not standardised. There are a few reports published on metyrapone use, mostly containing small patient numbers.Method: A retrospective survey was conducted across 13 tertiary centres. Using a standardised proforma, extensive data including monitoring and safety information were collected for patients with Cushing’s syndrome o...